TY - JOUR
T1 - Sustained heart rate-corrected QT prolongation during recovery from hypoglycaemia in people with type 1 diabetes, independently of recovery to hyperglycaemia or euglycaemia
AU - Andreasen, Christine R
AU - Andersen, Andreas
AU - Hagelqvist, Per G
AU - Maytham, Kaisar
AU - Lauritsen, Julius V
AU - Engberg, Susanne
AU - Faber, Jens
AU - Pedersen-Bjergaard, Ulrik
AU - Knop, Filip K
AU - Vilsbøll, Tina
N1 - This article is protected by copyright. All rights reserved.
PY - 2023/6
Y1 - 2023/6
N2 - AIM: To investigate changes in cardiac repolarization abnormalities (heart rate-corrected QT [QT
c ] [primary endpoint], T-wave abnormalities) and heart-rate variability measures in people with type 1 diabetes during insulin-induced hypoglycaemia followed by recovery hyperglycaemia versus euglycaemia.
METHODS: In a randomized crossover study, 24 individuals with type 1 diabetes underwent two experimental clamps with three steady-state phases during electrocardiographic monitoring: (1) a 45-minute euglycaemic phase (5-8 mmol/L), (2) a 60-minute insulin-induced hypoglycaemic phase (2.5 mmol/L), and (3) 60-minute recovery in either hyperglycaemia (20 mmol/L) or euglycaemia (5-8 mmol/L).RESULTS: All measured markers of arrhythmic risk indicated increased risk during hypoglycaemia. These findings were accompanied by a decrease in vagal tone during both hyperglycaemia and euglycaemia clamps. Compared with baseline, the QT
c interval increased during hypoglycaemia, and 63% of the participants exhibited a peak QT
c of more than 500 ms. The prolonged QT
c interval was sustained during both recovery phases with no difference between recovery hyperglycaemia versus euglycaemia. During recovery, no change from baseline was observed in heart-rate variability measures.
CONCLUSIONS: In people with type 1 diabetes, insulin-induced hypoglycaemia prolongs cardiac repolarization, which is sustained during a 60-minute recovery period independently of recovery to hyperglycaemia or euglycaemia. Thus, vulnerability to serious cardiac arrhythmias and sudden cardiac death may extend beyond a hypoglycaemic event, regardless of hyperglycaemic or euglycaemic recovery.
AB - AIM: To investigate changes in cardiac repolarization abnormalities (heart rate-corrected QT [QT
c ] [primary endpoint], T-wave abnormalities) and heart-rate variability measures in people with type 1 diabetes during insulin-induced hypoglycaemia followed by recovery hyperglycaemia versus euglycaemia.
METHODS: In a randomized crossover study, 24 individuals with type 1 diabetes underwent two experimental clamps with three steady-state phases during electrocardiographic monitoring: (1) a 45-minute euglycaemic phase (5-8 mmol/L), (2) a 60-minute insulin-induced hypoglycaemic phase (2.5 mmol/L), and (3) 60-minute recovery in either hyperglycaemia (20 mmol/L) or euglycaemia (5-8 mmol/L).RESULTS: All measured markers of arrhythmic risk indicated increased risk during hypoglycaemia. These findings were accompanied by a decrease in vagal tone during both hyperglycaemia and euglycaemia clamps. Compared with baseline, the QT
c interval increased during hypoglycaemia, and 63% of the participants exhibited a peak QT
c of more than 500 ms. The prolonged QT
c interval was sustained during both recovery phases with no difference between recovery hyperglycaemia versus euglycaemia. During recovery, no change from baseline was observed in heart-rate variability measures.
CONCLUSIONS: In people with type 1 diabetes, insulin-induced hypoglycaemia prolongs cardiac repolarization, which is sustained during a 60-minute recovery period independently of recovery to hyperglycaemia or euglycaemia. Thus, vulnerability to serious cardiac arrhythmias and sudden cardiac death may extend beyond a hypoglycaemic event, regardless of hyperglycaemic or euglycaemic recovery.
KW - Arrhythmias, Cardiac/chemically induced
KW - Cross-Over Studies
KW - Diabetes Mellitus, Type 1/complications
KW - Heart Rate
KW - Humans
KW - Hyperglycemia/chemically induced
KW - Hypoglycemia/chemically induced
KW - Hypoglycemic Agents/adverse effects
KW - Insulin, Regular, Human/adverse effects
KW - Long QT Syndrome/chemically induced
UR - http://www.scopus.com/inward/record.url?scp=85148525992&partnerID=8YFLogxK
U2 - 10.1111/dom.15005
DO - 10.1111/dom.15005
M3 - Journal article
C2 - 36752677
VL - 25
SP - 1566
EP - 1575
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 6
ER -